Navigation Links
Use of Novel FlashPlate Technology to Measure cAMP Accumulation in Chinese Hamster Ovary Cells Expressing Human -2 Adrenoreceptors

J. Watson
SmithKline Beecham Pharmaceuticals, UK

Introduction

Due to recent technologies in the pharmaceutical industry that have resulted in an increase in the production of potential drug candidates, it has become vital that screening assays are high throughput. FlashPlate technology from PerkinElmer Life Sciences has provided a platform for the adaptation of a variety of assays which can be automated. One such application is monitoring the activity of the enzyme adenylyl cyclase by measuring cAMP accumulation.

Until recently, cAMP has been generated in a biological system (e.g., receptor expressing cells), extracted and then measured by FlashPlate (SMP001) (FlashPlate File #7, J. Watson). However the recent introduction of a novel adenylyl cyclase FlashPlate assay (SMP004, SMP004A) has provided a more efficient method for measuring levels of cAMP from whole cells which eliminates the extraction step (FlashPlate File #1, P. Kasila).

We have investigated the use of this novel FlashPlate technology to measure the activation of adenylyl cyclase in Chinese Hamster Ovary (CHO) cells expressing human -2 adrenoreceptors (h-2 receptors).

Materials

Adenylyl Cyclase Activation FlashPlate Assays (96-well format) were supplied by PerkinElmer Life Sciences. Isoprenaline was obtained from Sigma-Aldrich, and pindolol from RBI chemicals. Hams F-12 media, foetal bovine serum and Geneticin 418 were obtained from Gibco BRL.

Method

CHO cells expressing h-2 receptors were grown to confluence in Hams F-12 media containing 10% foetal bovine serum and 500 μg/ml Geneticin 418, harvested and resuspended in stimulation buffer, containing a phosphodiesterase inhibitor, provided with the FlashPlate kit. The cells were then spun at 200 g for 5 mins. at room temperature, the supernatant removed and the pellet resuspended in stimulation buffer. A standard curve of known cAMP concentrations was constructed and pipetted into the designated wells. Cells (50 μl) were added to the remaining wells containing either water or test drug to give a final volume of 100 μl, and the plate incubated at 37C for 15 mins. The reaction was then terminated by addition of 100 μl of detection buffer containing 0.018 μCi of 125I-cAMP and membrane permeabilising reagent (provided with the FlashPlate kit). After 2 hrs. at room temperature, the FlashPlate was placed onto a Packard TopCount Microplate Scintillation Counter and the level of bound radioactivity measured.

Results

-2 adrenoreceptors are positively coupled to adenylyl cyclase and so stimulate the production of cAMP. It was important to establish the number of cells per well that would produce measurable basal and stimulated levels of cAMP, i.e., that would lie on the standard curve. Figure 1 shows a linear relationship between the number of cells added per well and basal levels of cAMP produced. The receptor agonist, isoprenaline (10 nM), stimulated cAMP levels approximately 5 fold for 1 x 105 and 5 x 105 cells per well, but could not be measured from the standard curve for 1 x 106 cells per well. These results suggest that a range from 1 x 105 to 5 x 105 cells per well could be used in this assay system. Because this assay is homogeneous, i.e., a uniform cell suspension is added to each well, we would expect very little intra-assay variation, as shown in Figure 2. Mean basal cAMP levels over 10 wells = 1.34 0.04 and isoprenaline-stimulated levels = 5.93 0.12, thus showing approximately 2% error between wells.

Isoprenaline stimulated cAMP accumulation (Fig. 3) with a pEC50 = 7.8 0.1 and could be dosedependently blocked by the receptor antagonist pind olol. Schild analysis of this data gave a pKb for pindolol = 9.1 0.1 (Fig. 4) which is consistent with its affinity for native receptors (Tsuchihashi et al . 1989). Pindolol also appeared to depress basal levels of cAMP (Fig. 3) which could be due to the presence of endogenous agonist or that pindolol has negative intrinsic activity.

Discussion

We have investigated the use of novel FlashPlate technology to directly measure cAMP accumulation in CHO cells expressing h-2 receptors. Previous assay methods involve a 2-step process: 1) generation of cAMP and 2) measurement of cAMP levels, whereas this new method is comprised of a single step process that can be carried out in either 96-well or 384-well FlashPlates.

Our studies revealed that 1 x 105 cells per well produced a suitable signal, although this may change depending on the cell line, receptor type and/or G protein-coupling involved. It is therefore essential to validate each new system that is to be used. Studies on assay variability showed the production of cAMP to be robust within plates, and measurement of pharmacological parameters of standard compounds (pEC50 for isoprenaline and pKb for pindolol) showed robust responses between plates.

In conclusion, Adenylyl Cyclase Activation FlashPlate Assay can be used to directly measure the production of cAMP from CHO cells expressing human -2 adrenoreceptors. This provides a simple method that can be easily automated and hence be used as a high-throughput assay.

References

P.A. Kasila. A Novel Adenylyl Cyclase Activation Assay on FlashPlate, FlashPlate File #1 , PerkinElmer Life Sciences (1998).

Tsuchihashi et al . Binding Characteristics of 3H-CGP12177 to -adrenoreceptors in Rat Myocardial Membranes. Japan. J. Pharmacol. 49, 11-19 (1989).

J. Watson. In Vitro Measurement of the Second Messenger cAMP: RIA vs. FlashPlate, FlashPlate File #7 , PerkinElmer Life Sciences (1998).


'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase
2. High-Fidelity PCR with a Novel Polymerase Mixture
3. Challenge the Performance of Your Hot-Start PCRs with FastStart Taq DNA Polymerase and the Novel FastStart High Fidelity PCR System
4. Combine High Yield, Great Accuracy and the Prevention of Carry-over Contamination by Using the Novel Expand High FidelityPLUS PCR System
5. Novel MicroRNA Array Technology for Sensitive miRNA Profiling
6. A Novel Process for Gene Expression Profiling of Rat and Mouse Tissues from Formalin-Fixed Paraffin-Embedded Sections Using Microarrays
7. ESR1 Gene Expression in Oncology and Metabolic Diseases Using the ASCENTATM System Target Validation and Identification of Novel Disease Indications
8. Novel Bonding Chemistry Imparts Enhanced Polar Selectivity to TSK-GEL ODS-100V Reversed Phase Columns
9. Unique Surface Treatment of Novel TSK-GEL ODS Columns Provide Separation of Aqueous and Fat Soluble Vitamins
10. Counting FlashPlates on the Wallac MicroBeta
11. Use of FlashPlate Technology for In Vitro Measurement of [35S]-GTPγS Binding in CHO Cells Expressing the Human 5-HT1B Receptor
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/11/2017)... Alto, CA, USA (PRWEB) , ... October 11, 2017 , ... ... set to take place on 7th and 8th June 2018 in San Francisco, CA. ... policy influencers as well as several distinguished CEOs, board directors and government officials from ...
(Date:10/11/2017)... 11, 2017  VMS BioMarketing, a leading provider of patient ... Clinical Nurse Educator (CNE) network, which will launch this week. ... among health care professionals to enhance the patient care experience ... and other health care professionals to help women who have ... ...
(Date:10/11/2017)... ... 2017 , ... Disappearing forests and increased emissions are the main causes of ... year. Especially those living in larger cities are affected by air pollution related diseases. ... most pollution-affected countries globally - decided to take action. , “I knew I had ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh ... orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of ... SBT-100 is able to cross the cell membrane and bind intracellular STAT3 and ...
Breaking Biology Technology:
(Date:4/24/2017)... 24, 2017 Janice Kephart , ... Identity Strategy Partners, LLP (IdSP) , today issues ... President Trump,s March 6, 2017 Executive Order: ... vetting can be instilled with greater confidence, enabling ... all refugee applications are suspended by until at ...
(Date:4/13/2017)... PUNE, India , April 13, 2017 According ... Identity Proofing, Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication ... by MarketsandMarkets™, the IAM Market is expected to grow from USD 14.30 ... Annual Growth Rate (CAGR) of 17.3%. ... ...
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
Breaking Biology News(10 mins):